AU5678398A - Sustained-release microspheres, their production and use - Google Patents

Sustained-release microspheres, their production and use

Info

Publication number
AU5678398A
AU5678398A AU56783/98A AU5678398A AU5678398A AU 5678398 A AU5678398 A AU 5678398A AU 56783/98 A AU56783/98 A AU 56783/98A AU 5678398 A AU5678398 A AU 5678398A AU 5678398 A AU5678398 A AU 5678398A
Authority
AU
Australia
Prior art keywords
sustained
production
release microspheres
microspheres
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56783/98A
Other languages
English (en)
Inventor
Yasutaka Igari
Shigeru Kamei
Tsutomu Ohta
Akira Saikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU5678398A publication Critical patent/AU5678398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
AU56783/98A 1997-01-29 1998-01-28 Sustained-release microspheres, their production and use Abandoned AU5678398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1520397 1997-01-29
JP9-15203 1997-01-29
PCT/JP1998/000339 WO1998032423A1 (fr) 1997-01-29 1998-01-28 Microspheres a liberation prolongee, leur production et utilisation

Publications (1)

Publication Number Publication Date
AU5678398A true AU5678398A (en) 1998-08-18

Family

ID=11882320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56783/98A Abandoned AU5678398A (en) 1997-01-29 1998-01-28 Sustained-release microspheres, their production and use

Country Status (2)

Country Link
AU (1) AU5678398A (fr)
WO (1) WO1998032423A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1048301A4 (fr) 1998-01-16 2005-03-09 Takeda Chemical Industries Ltd Compositions a liberation controlee, leur procede de fabrication et leur utilisation
CA2345213A1 (fr) * 1998-10-08 2000-04-13 Takeda Chemical Industries, Ltd. Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant
CO5160256A1 (es) * 1999-02-08 2002-05-30 Zentaris Ag Sales de peptidos farmaceuticamente activos para la liberacion sostenida y proceso de produccion
PL352499A1 (en) * 1999-07-15 2003-08-25 Takeda Chemical Industries Ltd Compositions of prolonged active substance release, method of obtaining them and their applications
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2002043766A1 (fr) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Compositions medicinales et leur procede de preparation
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
WO2002087616A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Remedes contre la recurrence postoperative du cancer du sein chez les femmes en premenopause
TWI332407B (en) 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
KR100994658B1 (ko) * 2001-12-26 2010-11-16 다케다 야쿠힌 고교 가부시키가이샤 신규 마이크로스피어 및 이들의 제조 방법
US7375073B2 (en) 2002-02-27 2008-05-20 Wake Forest University Health Sciences Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
CN1662260B (zh) 2002-06-25 2010-04-28 武田药品工业株式会社 缓释组合物的制备方法
AU2004253853B2 (en) 2003-04-10 2010-04-01 Evonik Corporation A method for the production of emulsion-based micro particles
AU2004259208B2 (en) * 2003-07-15 2011-04-28 Evonik Corporation Method for the preparation of controlled release formulations
CA2915574C (fr) 2003-07-18 2017-02-07 Oakwood Laboratories, L.L.C. Methode pour empecher la perte de poids moleculaire des polymeres, la formation d'impuretes et la gelification dans les composes polymeriques
EP2444069B1 (fr) * 2003-07-23 2019-06-05 Evonik Corporation Compositions à libération contrôlée
GB0326602D0 (en) * 2003-11-14 2003-12-17 Novartis Ag Organic compounds
MY158342A (en) * 2003-11-14 2016-09-30 Novartis Ag Pharmaceutical composition
CN101563068B (zh) 2006-12-18 2013-03-20 武田药品工业株式会社 缓释组合物和其制备方法
PE20090387A1 (es) * 2007-05-24 2009-04-28 Novartis Ag Formulacion de pasireotida
US20120065067A1 (en) * 2010-09-14 2012-03-15 The Regents Of The University Of California Pamoic acid blocks ethylene signaling
US9956164B2 (en) 2014-04-16 2018-05-01 Veyx-Pharma Gmbh Veterinary pharmaceutical composition and use thereof
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
CH679207A5 (fr) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
EP0626170A3 (fr) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilisation de composés pharmacoligiquement actifs dans des compositions à libération contrÔlée.
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung

Also Published As

Publication number Publication date
WO1998032423A1 (fr) 1998-07-30

Similar Documents

Publication Publication Date Title
AU5678398A (en) Sustained-release microspheres, their production and use
AU5734096A (en) Diamide-dicarboxylic acid microspheres
HK1019605A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
AU4772597A (en) Novel phospholipase, production and use thereof
GB9412585D0 (en) Microcapsules, their production and use
AU4426296A (en) G protein coupled receptor protein, production, and use thereof
AU6399798A (en) New catalysts
AU6311698A (en) Immunopotentiators
AU6204398A (en) Cast part, and production of same
AU8529998A (en) Biodegradable polyester urethanes, method for the production and use thereof
AU9781998A (en) Huchordin and uses thereof
AU4911496A (en) Multiple component rna catalysts and uses thereof
AU7550398A (en) Heterocyclic compounds, their production and use
AU9184998A (en) Processes for producing n,n-dialkylallylamine polymers and n,n-dialkylallylaminepolymers
AU5983496A (en) Improved uniformly plated microsphere catalyst
AU7095296A (en) Phosphorylamides, their preparation and use
AU6016896A (en) Heterocyclic compounds, their production and use
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
GB2303634B (en) Basic azo compounds,their production and use
ZA985973B (en) Organotin sulfonate catalysts and their manufacture.
AU7474998A (en) Haloisoquinoline carboxamide
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU5468896A (en) Polypeptides, their production and use
HUP0000498A3 (en) Novel calpaines, production and use thereof
AU4483696A (en) Novel peptides, their production and use